Chemistry Reference
In-Depth Information
Table 18.2 reported studies on the use of Probiotics in the remission of
Inflammatory bowel Diseases
Disease
state
Probiotic Product used
Details of study
Clinical Effect
ref.
ibd
Bifidobacterium bifidum
bgn4
Conventional diet
containing only
skim milk or a
diet containing
skim milk with
0.3 percent
(w/w) bgn4 for
4 weeks
bgn4
supplemented
diet could be
helpful for the
control of
aberrant immune
responses in the
intestinal tissue
172
Lactobacillus rhamnosus
gg (Lgg),
Streptococcus
thermophilus
tH-4 (tH-4),
Bifidobacterium lactis
bb12 (bb12), and
Lactobacillus fermentum
br11
1 × 10
10
Cfu/mL
orally twice
daily for 14 days
Lactobacillus
fermentum
br11
was most
effective at
reducing colitic
symptoms
173
Bifidobacterium,
Lactobacillus,
and
Enterococcus
1,260 mg/d three
times daily for 4
weeks
administration of
live combined
Bifidobacterium,
Lactobacillus
,
and
Enterococcus
improved the
symptom of
irritable bowel
syndrome
174
a dietary integrator (ibs
active), composed of
l-tryptophan, inulin,
angelica, vegetal charcoal,
vitamin PP, group b
vitamins (b
1
, b
2
, b
6
) and
probiotics (
Lactobacillus
sporogenes, Lactobacillus
acidophilus, Streptococcus
thermophilus)
ibs active (440
mg twice daily)
over a mean
period of 6
months
ibs active led to a
significant
improvement in
pain symptoms,
abdominal
distension, and
regulation of
bowel movement
175
a symbiotic consisting of a
probiotic,
Bifidobacterium
longum
W11, and the
short-chain
oligosaccharide prebiotic
fos actilight
3 g/day for at
least 36 days
Product can
increase stool
frequency in
patients with
constipation-
variant ibs and
reduce
abdominal pain
and bloating
176
Crohn's
disease
Saccharomyces boulardii
in combination
with
mesalamine
the combination
was found to be
more effective in
the maintenance
treatment of
inactive Crohn's
disease
177
